Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non Small-Cell Lung Cancer Article

Industry Collaboration International Collaboration

cited authors

  • Wakelee, Heather; Zvirbule, Zanete; De Braud, Filippo; Kingsley, C. Daniel; Mekhail, Tarek; Lowe, Thomas; Schuette, Wolfgang; Lena, Herve; Lawler, William; Braiteh, Fadi; Cosgriff, Thomas; Kaen, Diego; Boyer, Michelle; Hsu, Jessie; Phan, See; Novello, Silvia

authors

Publication Date

  • January 1, 2017

webpage

published in

category

keywords

  • Biomarkers
  • Combination therapy
  • MET
  • Phase II clinical trial
  • Progression-free survival

start page

  • 50

end page

  • 59

volume

  • 18

issue

  • 1